Etodolac/Propranolol
依托度酸/普萘洛尔
Report date: 2022/11/25 17:57:02
Base Information
Drug NameEtodolac/Propranolol
Drug Alias Name +[10]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsYes Propranolol hydrochlorideEtodolac
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesVicus Therapeutics Llc
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesVicus Therapeutics Llc
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A